Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

NCT04519671 is registered in ClinicalTrials.gov with Anthony Lembo as lead sponsor.

NCT NCT04519671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Lead sponsor
Anthony Lembo
Phase
Phase 1/2
Overall status
Terminated
Start date
November 19, 2020
Completion date
November 16, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, perianal crohn disease, perianal fistula